Should You Take Statins? Study Says Heart Benefits Outweigh Diabetes Risk
In February, the U.S. Food and Drug Administration (FDA) added a new warning to cholesterol-lowering statin drugs, noting the increased risk of Type 2 diabetes in users. But now a new study suggests that the cardiovascular benefits of taking the drugs may outweigh any potential diabetes risk.
The new study, published in the journal Lancet, analyzed existing data from the well-known and controversial 2008 JUPITER trial (for Justification for the Use of Statins in Primary Prevention), which tested a single statin, Crestor (rosuvastatin), for the prevention of heart disease in healthy people with no history of heart problems.
It’s well-established that taking statins reduces cardiovascular risks in people who already have heart disease. But the JUPITER trial found that healthy people with no heart disease or high cholesterol — but with high levels of C-reactive protein (CRP), a marker for inflammation — also had significantly lower risks of nonfatal heart attacks and stroke when taking Crestor, compared with people not taking the drug. Those findings prompted the FDA to expand the eligible patient population for Crestor by millions.
கருத்துகள் இல்லை:
கருத்துரையிடுக